Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
180
datasets available to search
ShareScore release 0.9.0
Dataset results
180 results for “FOLFIRI”
A Study of Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin Chemotherapy
ClinicalTrials.gov study NCT01661270. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan
ClinicalTrials.gov study NCT01882868. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01298570. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS Mutation
ClinicalTrials.gov study NCT03829410. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients Wit
ClinicalTrials.gov study NCT05004350. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines
ClinicalTrials.gov study NCT04535401. IPD Sharing: YES. Countries: 1. Publications: 1.
MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab
ClinicalTrials.gov study NCT04554836. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab
ClinicalTrials.gov study NCT03368859. IPD Sharing: YES. Countries: 6. Publications: 1.
Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encora
ClinicalTrials.gov study NCT02928224. IPD Sharing: YES. Countries: 27. Publications: 7.
Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer
ClinicalTrials.gov study NCT00210184. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT02181556. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT00457691. IPD Sharing: Not stated. Countries: 34. Publications: 1.
Study Of Sunitinib With FOLFIRI In Colorectal Cancer
ClinicalTrials.gov study NCT00668863. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
ClinicalTrials.gov study NCT01479465. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT00921661. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas
ClinicalTrials.gov study NCT03387592. IPD Sharing: Not stated. Countries: 1. Publications: 2.
FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum
ClinicalTrials.gov study NCT00077233. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC
ClinicalTrials.gov study NCT01996306. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor
ClinicalTrials.gov study NCT01123876. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients with Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy
ClinicalTrials.gov study NCT03081143. IPD Sharing: NO. Countries: 3. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.